Please login to the form below

Not currently logged in
Email:
Password:

Deloitte

This page shows the latest Deloitte news and features for those working in and with pharma, biotech and healthcare.

Health insurers will test blockchain for data handling

Health insurers will test blockchain for data handling

A Deloitte report on the application of blockchain to healthcare published in 2016 predicted that the technology could “provide a new model for health information exchanges (HIE) by making electronic medical

Latest news

  • Pharma is ‘getting lower returns on R&D’ Pharma is ‘getting lower returns on R&D’

    Pharma is ‘ getting lower returns on R&D’. And Deloitte says the number of drugs in late-stage trials tumbled by 16%. ... almost $2bn compared to $1.2bn in 2010 when the annual survey - by Deloitte’s Centre for Health Solutions - was first conducted

  • Real-world evidence Real-world evidence

    life science partner and RWE specialist at analysts Deloitte. “

  • Brexit: Medical research and the EU referendum Brexit: Medical research and the EU referendum

    In the interests of balance. In February, Karen Taylor, research director for Deloitte's UK Centre for Health Solutions, authored a corporate blog on the potential impact of Brexit for the

  • Study shows R&D returns too low in pharma to be sustainable Study shows R&D returns too low in pharma to be sustainable

    The numbers simply do not add up for life sciences R&D to generate an appropriate return," notes Deloitte. ... While the outlook shows uncertain times for the industry, the solutions appear to be relatively straightforward," commented Neil Lesser, life

  • For richer or poorer For richer or poorer

    Deloitte's Global Human Capital Trends 2015 says that the balance of power in the employer/employee relationship has shifted 'making today's employees more like customers or partners than subordinates.' ... As such, Deloitte's report urges business

More from news
Approximately 1 fully matching, plus 15 partially matching documents found.

Latest Intelligence

  • The rise of real-world evidence The rise of real-world evidence

    More than half the leading life science companies polled by Deloitte in 2017 were developing or significantly improving their real-world data (RWD) capabilities.

  • A quest for innovative solutions A quest for innovative solutions

    The report from analysts Deloitte in December last year, A New Future for R&D?, highlighted diminishing revenue returns from traditional drug development models but stated: ‘We see opportunities for biopharma

  • Digitally yours: How to build effective relationships in virtual space Digitally yours: How to build effective relationships in virtual space

    It is not all about saving though. A 2015 Deloitte forecast estimates considerable growth opportunities in the global mobile and digital health market, with a forecasted rise from $2.4 billion

  • Deal Watch December 2015 Deal Watch December 2015

    December saw the release of reports by two of the top accountancy and consulting groups, PWC and Deloitte. ... Deloitte and GlobalData's report Measuring the return from pharmaceutical innovation 2015 - transforming R&D returns in uncertain times

  • The Chinese diabetes challenge The Chinese diabetes challenge

    However, according to a report published by audit and consulting firm Deloitte, China's Ministry of Civil Affairs has set an ambitious target to train six million caregivers by the end

More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 8 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Just::Health Communications

Just:: is a different kind of healthcare communications agency. Since 2006, we’ve been collaborating with clients around the world to...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics